MR [Mindray Medical International] CORRESP: November29, 2012 STYLE=”font-family:Times New Roman” SIZE=”2″>Mr.Martin James Seniorsistant

[November29, 2012 STYLE="font-family:Times New Roman" SIZE="2">Mr.Martin James Seniorsistant Chief Accountant Division ofrporation Finance 100 F Street, NE Re: Mindray Medical International Limited Form 20-F for the Fiscal Year Ended December 31, 2011 Filed April 30, 2012 File No. 001-33036 Dear Mr.James: Mindraymment Letter 2011 Form 20-Fmmission STYLE="font-family:Times New Roman" SIZE="2">On behalf of Mindray Medical International]

MR [Mindray Medical International] CORRESP: The Staffsmment is duly noted. Mindrayvises the Staff

[The Staffsmment is duly noted. Mindrayvises the Staff that it hasopted the new policy described below effective November 1, 2012, prospectively, and will supplement its future filings with the below proposed disclosure follows: We purchase export credit insurance to mitigate the risk of loss and accounts receivable impairment on shipments to our international distributors who]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Medical Announces Top Management Change SHENZHEN, China, November 5, 2012 /PRNewswire-FirstCall/ — Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that Mr. Xu Hang, has resigned from his co-chief executive officer (co-CEO) position, effective immediately, but will continue to serve as Mindray’s chairman. Mr. Li Xiting, Mindray’s president and]

MR [Mindray Medical International] 6-K: Mindray Medical Announces Top Management Change SHENZHEN, China,

[Mindray Medical Announces Top Management Change SHENZHEN, China, November 5, 2012 /PRNewswire-FirstCall/ — Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that Mr. Xu Hang, has resigned from his co-chief executive officer (co-CEO) position, effective immediately, but will continue to serve as Mindray’s chairman. Mr. Li Xiting, Mindray’s president and]

By | 2016-03-04T06:23:55+00:00 November 5th, 2012|Categories: Chinese Stocks, MR, Webplus ver|Tags: , , , , , |0 Comments

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces Third Quarter 2012 Financial Results Shenzhen, China – November 5, 2012 – Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter ended September 30, 2012. Highlights for Third Quarter 2012 • Net revenues were $257.1 million, up 17.7% over the]

Skip to toolbar